Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Agree!!!
Because it’s better to be right than first.
This will all play out soon enough.
Add it to the list!!!!
Can we do a compiled thread about anavex curing paralysis? May as well do blindness while we are at it.
Separate discussion. My personal view is that I don’t care about current market cap and I think fretting about it now is a useless waste of time. If the drug works it will be higher - significantly higher. We aren’t that far away from knowing. Relax and enjoy the ride.
In reality, the PR wasn’t great. There isn’t enough for people to make a firm call in yet. It looks promising but that isn’t enough yet. If results continue to come in like this or better, which I think they will, we will all be happy and this short term noise won’t matter.
This is my view as well. It’s ok, but important to remember it’s only 7 weeks and it’s low dose. It is certainly more positive than negative. And we wait.......
Good luck. Keep us posted.
I may be getting trials confused, was seizure tracking part of this one? I don’t think saw any mention on that.
Only 7 weeks treatment AND low dose. That should bode well for future results
Excellent first step.
This is all wonderful if the drug works. If it doesn’t then it’s a colossal waste of time.
We will know soon enough. The trials are all that matter.
Heavens to murgatroyd. We agree on something!
Now if we could all just stop over analyzing the trivial stuff while we wait.
Enjoy the ride - it’s either going to have a thrilling and profitable conclusion or be an absolute train wreck.
This statement has no basis in reality.
We should focus on important things.
I’m sure this is it.
The ACAD news in no way implies anything about Anavex results - nothing but pure hopeful speculation.
Public ceo statements count only when they are true. Thus far we have had lots of statements and very little backing up.
I think we should start with getting one thing approved first. Then maybe solve all of humanities problems second?
Ok, I’ll play along. You think there is a 90 percent chance of success, or better.
If the first trial fails, what does that percent go to.
This is the correct view. It’s either going to work or it’s not - and we will know soon enough. Articles, “great finds!!!!”, great news any day now, or random tweets aren’t going to change what the science/trials will tell us.
What’s the point? Investors are betting the trials will disappoint. I don’t agree with that particular viewpoint, but so be it. We will all find out soon enough.
I don’t see any number on the list higher than the current short interest - so from that basic perspective most people would recognize that as a record.
One is welcome to shuffle the chairs and point out that it is not a record as a percent of float. Also true but doesn’t negate the point being made.
Please provide a specific location in the 10-q for this language. I just looked and Only see reference to 2/3.
No, but it’s certainly heavily implied.
I didn’t say he was an employee. My thesis here is the conjecture that he left as part of a master plan is nothing but wishful thinking. That’s all.
Wishful thinking. It’s quite a stretch to make a claim that he’s leaving a company to help it.
Hampel was so excited he left.
How can his opinion be incorrect?
I agree. It’s not happening. It doesn’t make any sense given the fact pattern. It’s nothing but false hope.
The drug will either work or it won’t. We will find out soon enough. I think it has better chance than not of a positive result.
It doesn’t say he was on 2-73. They interviewed a guy with PD.
What about MTA?